<< Back To Authors

Overview

Liz Highleyman

Liz is Science Editor for Cancer Health, POZ, Hep and Real Health. She has been a health journalist and medical editor for more than 20 years, covering HIV, viral hepatitis, cancer and other health issues.

Articles

Can Stopping Antivirals Lead to a Functional Cure for Hepatitis B?

Most people who stopped long-term nucleoside/nucleotide analogs did not need to restart treatment.

Tagrisso After Lung Cancer Surgery Cuts Risk of Death by Half

The oral targeted therapy led to a 51% improvement in survival for patients with EGFR-mutated non-small-cell lung cancer.

Cancer Immunotherapy as a human immune system therapy concept as a biomedical or biomedicine oncology treatment using the natural T cell fighting properties of the body as a 3D render.

Immunotherapy Combo Improves Cervical Cancer Survival

Keytruda plus chemotherapy reduced the risk of death by about 40% for people with persistent, recurrent or metastatic cervical cancer.

Two Experimental Therapies Show Promise for NASH

VK2809 and pegozafermin are among several medications coming through the pipeline for fatty liver disease

Can Weight Loss Drugs Help Immune Cells Fight Cancer?

GLP-1 analog medications improved the functionality of cancer-fighting natural killer cells.

Coming Out as Cured

Marc Franke is part of an exclusive circle of people cured of HIV after a stem cell transplant to treat cancer.

Experimental mRNA Vaccine Shows Promise for Pancreatic Cancer

A personalized neoantigen vaccine from BioNTech and Roche/Genentech lowered the risk of relapse after surgery.

Study Identifies Features of Long COVID Neurological Symptoms

Findings from NIH study offer insight into biological mechanisms, pointing to possible treatments.

Hot topics

Breast Cancer

Lung Cancer

Liver Cancer

Prostate Cancer

Cancer Treatment

Cancer Screening

Ovarian Cancer

Blood Cancers - Leukemia/Lymphoma/Multiple Myeloma

gloved hand needle vial vaccine coronavirus

FDA and CDC Change COVID Vaccine Recommendations

People 65 and older and immunocompromised people can get a second bivalent booster; most unvaccinated people now need only one initial shot.

NAFLD Linked to Severe COVID Among Younger People

A second meta-analysis found that people with cirrhosis had higher COVID mortality.

Is there a vaccine to prevent cancer?

Human papillomavirus and hepatitis B vaccines lower the risk of developing cancer.

girl receiving vaccine from female doctor

Many People Don’t Know HPV Causes Cancer

Vaccines could potentially eliminate cervical, anal, oral and other cancers caused by human papillomavirus.

Coronavirus or sars-cov-2 virus cell with messenger RNA or mRNA and syringe

Experimental mRNA Vaccine Plus Keytruda Delays Melanoma Recurrence

Moderna and Merck’s personalized neoantigen vaccine plus checkpoint inhibitor lowered the risk of disease progression after surgery by 44%.

Medical Marijuana Legalization Linked to Less Opioid Use

Cancer patients were prescribed less opioids and had fewer hospital visits for pain in states that allow medical cannabis.

Checkpoint Immunotherapy Delays Endometrial Cancer Progression

Both Jemperli and Keytruda improved progression-free survival in late-stage clinical trials.

Many Men Can Delay Prostate Cancer Treatment

After 15 years, survival rates were similar for patients who were treated promptly and those who received active monitoring.